Stockholm, Sweden

Goran Lindroos

This inventor holds 1 USPTO granted patent. Top assignee: Ab Kabi. Active years: 1977.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Goran Lindroos: Innovator in Blood Coagulation Factor Isolation

Introduction

Goran Lindroos is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of biochemistry, particularly in the isolation of blood coagulation factors. His work has implications for medical treatments and research in hematology.

Latest Patents

Goran Lindroos holds a patent for the isolation of coagulation factors I and VIII from biological material. This innovative process allows for the high-yield extraction of fibrinogen and antihemophilia factor from animal tissues, such as blood or blood products. The method involves the adsorption of these factors onto a water-insoluble gel matrix, primarily composed of cross-linked sulfated or sulfonated gel-forming carbohydrates.

Career Highlights

Goran Lindroos is associated with Ab Kabi, a company that focuses on biopharmaceuticals and medical technologies. His work at Ab Kabi has been instrumental in advancing the understanding and application of blood coagulation factors in clinical settings.

Collaborations

Throughout his career, Goran has collaborated with esteemed colleagues, including Lars-Olov Andersson and Hakan Gunnar Borg. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Goran Lindroos is a prominent figure in the field of biochemistry, with a focus on blood coagulation factors. His patent and work at Ab Kabi highlight his contributions to medical science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…